Coagulopathy due to a thrombosis event has been observed in COVID-19 patients, with elevated D-dimer and fibrinogen, although with no significant prolonged prothrombin time and activated partial thromboplastin time25,26,113. This evidence concerns the gene F2 and deep vein thrombosis.